Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P17931 (
galectin-3
)
2,860
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Tumor development involves complex bidirectional interactions between tumor cells and host stromal cells.
Endosialin
(Tem1) has been identified as a highly O-glycosylated transmembrane glycoprotein, which is specifically expressed by tumor vessel-associated pericytes and stromal fibroblasts of a wide range of human tumors. Recent experiments in
endosialin
-deficient mice have unraveled a critical role of
endosialin
in site-specific tumor progression and metastasis. To molecularly understand the mechanisms of
endosialin
function, we aimed to identify extracellular
endosialin
ligands and identified Mac-2 BP/90K as a specific interaction partner. Detailed biochemical analyses identified a C-terminal fragment of Mac-2 BP/90K, which was shown to contain binding sites for
galectin-3
, and collagens as the structures responsible for
endosialin
binding. Subsequent expression analysis of Mac-2 BP/90K in vivo revealed weak or no expression in most normal tissues and strong up-regulation in tumor cells of human neoplastic tissues. Intriguingly, the expression patterns of Mac-2 BP/90K and
endosialin
were mutually exclusive in all human tissues. Correspondingly, loss-of-function adhesion experiments of Mac-2 BP/90K-expressing tumor cells on
endosialin
-expressing fibroblasts revealed a repulsive outcome of the Mac-2 BP/90K interaction. Taken together, the experiments identify a novel repulsive interaction between
endosialin
on stromal fibroblasts and Mac-2 BP/90K on tumor cells.
...
PMID:Tumor stroma marker endosialin (Tem1) is a binding partner of metastasis-related protein Mac-2 BP/90K. 1849 Mar 83
The role of fibroblasts in tissue fibrosis has been extensively studied. Activated fibroblasts, namely myofibroblasts, produce pathological extracellular matrix.
CD248
, a type I transmembrane glycoprotein, is expressed in fibroblasts after birth. In human chronic kidney disease, upregulated
CD248
in myofibroblasts is linked to poor renal survival. In this study, we demonstrated a novel interaction between
CD248
and macrophages to be a key step in mediating tissue fibrosis.
CD248
was upregulated in myofibroblasts in murine models of renal and peritoneal fibrosis. Cd248 knockout (Cd248
-/-
) could attenuate both renal and peritoneal fibrosis. By parabiosis of GFP reporter mice and Cd248
-/-
mice, we showed that attenuation of renal fibrosis was associated with a decrease of macrophage infiltration in Cd248
-/-
mice. Moreover, decrease of chemokine (C-C motif) ligand 17 and Ccl22 was found in macrophages isolated from the fibrotic kidneys of Cd248
-/-
mice. Because
galectin-3
-deficient macrophages showed decreased Ccl17 and Ccl22 in fibrotic kidneys, we further demonstrated that
CD248
interacted specifically with
galectin-3
of macrophages who then expressed CCL17 to activate collagen production in myofibroblasts. Mice with DNA vaccination targeting
CD248
showed decreased fibrosis. We thus propose that
CD248
targeting should be studied in the clinical tissue fibrosis setting.
...
PMID:Targeting fibroblast CD248 attenuates CCL17-expressing macrophages and tissue fibrosis. 3303 77